203 related articles for article (PubMed ID: 37454039)
1. Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil.
Correa LP; da Costa Farias F; Dos Santos Barile KA; Palmeira MK; de Melo Amaral CE
Braz J Microbiol; 2023 Sep; 54(3):1745-1750. PubMed ID: 37454039
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and molecular profile of blood donors infected with HTLV-1/2 in the state of Pará, northern Brazil.
de Alcantara Maneschy C; Dos Santos Barile KA; de Castro JAA; Palmeira MK; de Castro RBH; de Melo Amaral CE
Braz J Microbiol; 2021 Dec; 52(4):2001-2006. PubMed ID: 34498218
[TBL] [Abstract][Full Text] [Related]
3. HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil: Prevalence, molecular characterization, and evidence of intrafamilial transmission.
Ribeiro IP; Kozlowski AG; Dias de Matos MA; da Costa E Silva ÁM; Dos Santos Carneiro MA; Vicente ACP; Martins RMB
J Med Virol; 2018 Oct; 90(10):1651-1657. PubMed ID: 29797609
[TBL] [Abstract][Full Text] [Related]
4. [Molecular characterization of HTLV-1/2 among blood donors in Belém, State of Pará: first description of HTLV-2b subtype in the Amazon region].
Santos EL; Tamegão-Lopes B; Machado LF; Ishak Mde O; Ishak R; Lemos JA; Vallinoto AC
Rev Soc Bras Med Trop; 2009; 42(3):271-6. PubMed ID: 19684974
[TBL] [Abstract][Full Text] [Related]
5. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
6. Decline in human T-cell lymphotropic virus seroprevalence in blood donors from Minas Gerais, Brazil over a 12-year period (2006-2017).
da Silva Malta MCF; Silva SMN; de Oliveira MB; Ribeiro MA; Martins ML
J Med Virol; 2022 Nov; 94(11):5535-5542. PubMed ID: 35855523
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.
Pinto MT; Rodrigues ES; Malta TM; Azevedo R; Takayanagui OM; Valente VB; Ubiali EM; Covas DT; Kashima S
Rev Inst Med Trop Sao Paulo; 2012; 54(3):123-9. PubMed ID: 22634882
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of infection by human T Cell lymphotropic viruses (HTLV-1/2) in adult population in Vitória-ES.
Orletti MPS; Assone T; Sarnaglia GD; Martins ML; Rosadas C; Casseb J; Taylor G; Ferreira-Filho JB; Pereira FEL; Miranda AE
Braz J Infect Dis; 2021; 25(5):101631. PubMed ID: 34656523
[TBL] [Abstract][Full Text] [Related]
9. Decline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007.
Dias-Bastos MR; Oliveira CD; Carneiro-Proietti AB
Rev Soc Bras Med Trop; 2010; 43(6):615-9. PubMed ID: 21181009
[TBL] [Abstract][Full Text] [Related]
10. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
[TBL] [Abstract][Full Text] [Related]
12. Moderate endemicity of the human T-lymphotropic virus infection in the metropolitan region of Belém, Pará, Brazil.
Silva IC; Pinheiro BT; Nobre AFS; Coelho JL; Pereira CCC; Ferreira LSC; Almeida CPS; Viana MNDSA; Almeida DS; Falcão JR; Santos YCVD; Araújo MWL; Borges MDS; Nascimento LD; Valentim LS; Casseb JSDR; Costa CAD; Sousa MS
Rev Bras Epidemiol; 2018 Oct; 21():e180018. PubMed ID: 30328937
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 and HTLV-2 Infection Among Warao Indigenous Refugees in the Brazilian Amazon: Challenges for Public Health in Times of Increasing Migration.
Abreu IN; Lopes FT; Lima CNC; Barbosa ADN; de Oliveira LR; Fujishima MA; Freitas FB; Dos Santos MB; de Lima VN; Cayres-Vallinoto IMV; Castelo-Branco S; da Silva HP; Vallinoto ACR
Front Public Health; 2022; 10():833169. PubMed ID: 35223744
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of human T-cell lymphotropic virus coinfecting human immunodeficiency virus 1 infected patients in the Amazon region of Brazil.
Laurentino RV; Lopes IG; Azevedo VN; Machado LF; Moreira MR; Lobato L; Ishak MO; Ishak R; Vallinoto AC
Mem Inst Oswaldo Cruz; 2005 Jul; 100(4):371-6. PubMed ID: 16113884
[TBL] [Abstract][Full Text] [Related]
16. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
Lee YH; Lu CT; Feng IJ; Hung CM
Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon.
Brito WRDS; Cardoso-Costa GL; Roland Junior LM; Pereira KAS; Lopes FT; Dos Santos BC; de Lima ACR; Abreu IN; Lima CNC; Lima SS; Cayres Vallinoto IMV; Dos Santos EJM; Guerreiro JF; Vallinoto ACR
Front Public Health; 2022; 10():871865. PubMed ID: 35433598
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R
Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074
[TBL] [Abstract][Full Text] [Related]
19. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
